**Question:** Which of the following factors are deficient in patients under warfarin therapy:

A. Vitamin K
B. Prothrombin
C. Activated partial thromboplastin time (aPTT)
D. International Normalized Ratio (INR)

**Correct Answer:**

**Core Concept:**
Warfarin is a widely used anticoagulant drug that interferes with vitamin K-dependent clotting factors synthesis in the liver. Vitamin K is essential for the post-translational modification of clotting factors II, VII, IX, X, protein C, and protein S. These clotting factors are involved in the intrinsic and common pathways of blood coagulation.

**Why the Correct Answer is Right:**

Vitamin K is the key factor that is deficient in patients under warfarin therapy. Warfarin inhibits vitamin K-dependent clotting factors synthesis by binding to vitamin K epoxide reductase (VKOR) complex, thereby preventing the reduction of vitamin K epoxide to vitamin K hydroquinone. This leads to a deficiency of vitamin K-dependent clotting factors, which results in impaired blood clotting.

**Why Each Wrong Option is Incorrect:**

- B. Prothrombin: Prothrombin is a clotting factor (factor II) that plays a role in the common pathway of blood coagulation. However, the deficiency of prothrombin alone does not explain the coagulopathy induced by warfarin therapy, as it is just one of the vitamin K-dependent clotting factors affected by warfarin.

- C. Activated partial thromboplastin time (aPTT): aPTT is a screening test for coagulation factor deficiencies and not a specific test for vitamin K deficiency. While aPTT may be elevated in warfarin-induced coagulopathy, it does not directly address the deficiency of vitamin K-dependent clotting factors.

- D. International Normalized Ratio (INR): INR is a standardized measure of coagulation, which is influenced by a variety of factors, including vitamin K deficiency and liver dysfunction. However, like aPTT, INR is not specific to vitamin K deficiency and does not directly reflect the deficiency of vitamin K-dependent clotting factors.

**Clinical Pearl:**

Warfarin, a vitamin K antagonist, is primarily used to prevent blood clots, heart attacks, and strokes due to its effect on vitamin K-dependent clotting factors. Inhibition of vitamin K-dependent clotting factors leads to a prothrombin time (PT) prolongation, which is the primary indicator of vitamin K deficiency induced by warfarin therapy.

**Why Vitamin K is essential:**

Vitamin K is an essential cofactor for the post-translational modification of clotting factors (factors II, VII, IX, X, protein C, and protein S). Warfarin's inhibition of VKORC1 complex leads to a deficiency of these clotting factors, resulting in a prothrombin time (PT) prolongation.

**Why is PT the correct test for